Position in CRSP
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$163
+$21 QoQ
Shares Held
3
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#509
of 522 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nalls Sherbakoff Group, LLC holds $12,247 across 2 Biotechnology names. CRSP ranks #2 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHAR |
Pharming Group N.V.
|
870 | $12,084 | |
| 2 | CRSP |
CRISPR Therapeutics AG
This page
|
3 | $163 |
All Filings in CRSP
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $163 | 3 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $142 | 3 | Shares | Sole | 2026-08-17 | |
| 2025-12-31 | $157 | 3 | Shares | Sole | 2026-03-12 | |
| 2025-09-30 | $194 | 3 | Shares | Sole | 2026-03-12 | |
| 2025-06-30 | $145 | 3 | Shares | Sole | 2026-03-12 | |
| 2025-03-31 | $238 | 7 | Shares | Sole | 2026-03-12 | |
| 2023-12-31 | $438 | 7 | Shares | Sole | 2024-04-09 | |
| 2023-09-30 | $317 | 7 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $392 | 7 | Shares | Sole | 2023-10-17 | |
| 2023-03-31 | $316 | 7 | Shares | Sole | 2023-10-17 | |
| No filing history on record for this holder in this stock. | ||||||